# A Study of ZN-c5 in Subjects With Breast Cancer

> **NCT03560531** · PHASE1,PHASE2 · COMPLETED · sponsor: **Zeno Alpha Inc.** · enrollment: 181 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** ZN-c5
- **DRUG:** Palbociclib

## Key facts

- **NCT ID:** NCT03560531
- **Lead sponsor:** Zeno Alpha Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-30
- **Primary completion:** 2022-04-26
- **Final completion:** 2022-12-22
- **Target enrollment:** 181 (ACTUAL)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03560531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03560531, "A Study of ZN-c5 in Subjects With Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03560531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*